Page breadcrumb nav

VAERS Report 2156701

Case Report Section

Détails du rapport Vaer

Âge: 31 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-13
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

bnt162b2 as dose 4 (booster); bnt162b2 as dose 4 (booster); vomiting; diarrhoea; muscle ache; felt faint; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. regulatory number: gb-mhra-webcovid-202202140957573400-immtk (agency). other case identifier(s): gb-mhra-adr 26600423 (agency). a 31 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 13feb2022 (batch/lot number: unknown) at the age of 31 years as dose 4 (booster), single for covid-19 immunisation. relevant medical history included: "inflammatory bowel disease" (unspecified if ongoing), notes: patient was taking medicines for inflammatory bowel disease (crohn's disease, ulcerative colitis); "crohn's disease" (unspecified if ongoing), notes: patient was taking medicines for inflammatory bowel disease (crohn's disease, ulcerative colitis); "ulcerative colitis" (unspecified if ongoing), notes: patient was taking medicines for inflammatory bowel disease (crohn's disease, ulcerative colitis). the patient took concomitant medications. vaccination history included: covid-19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 2; manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 3; manufacturer unknown), for covid-19 immunisation. the patient's last menstrual date was 14feb2022. the patient was not pregnant and was not breastfeeding at the time of this report. the patient had no symptoms associated with covid-19 and was not enrolled in the clinical trial. patient has not tested positive for covid-19 since having the vaccine. the following information was reported: off label use (medically significant), immunisation (medically significant) all with onset 13feb2022, outcome "unknown" and all described as "bnt162b2 as dose 4 (booster)"; vomiting (medically significant) with onset 13feb2022, outcome "recovering", described as "vomiting"; diarrhoea (medically significant) with onset 13feb2022, outcome "recovering", described as "diarrhoea"; myalgia (medically significant) with onset 13feb2022, outcome "not recovered", described as "muscle ache"; dizziness (medically significant) with onset 13feb2022, outcome "not recovered", described as "felt faint". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative covid-19 test. this report was not related to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
Liste des symptômes
diarrhoea vomiting dizziness myalgia sars-cov-2 test immunisation off label use
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na